COST of acute exacerbation of COPD in patients attending government hospital in Kerala, India

International Journal of Pharmacy and Pharmaceutical Sciences

Volumn 4, Issue SUPPL.3, 2012, Pages 659-661

  Veettil, Sajesh K ^a   Salmiah, M A ^a   Rajiah, Kingston ^a   Suresh Kumar, B R ^a  

^a INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

COPD; Cost; Exacerbation; Government; India; Kerala

Indexed keywords

AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST BENEFIT ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GOVERNMENT; HOSPITAL; HOSPITALIZATION COST; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OXYGEN THERAPY; PRIMARY HEALTH CARE; PROSPECTIVE STUDY;

EID: 84873487750     PISSN: None     EISSN: 09751491     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. GOLD Scientific Committee Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD). Am J Respir Crit Care Med. 2001; 163(5).
2. Marc Miravitlles, Cristina Murio, Tina Guerrero, and Ramon Gisbert, for the DAFNE study group. Pharmacoeconomic Evaluation of Acute Exacerbations of Chronic Bronchitis and COPD, Chest, 2002; 121; 1449-1455.
3. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1995; 152 (5pt 2): S77-S121.
4. Daniel E. Hilleman, PharmD; Naresh Dewan, Mark Malesker and Mitchell Friedman. Pharmacoeconomic Evaluation of COPD, Chest, 2000; 118; 1278-1285.
5. Sven-Arne Jansson, Fredrik Andersson, Sixten Borg, et al. Costs of COPD in Sweden According to Disease Severity, Chest, 2002; 122; 1994-2002.
6. Sean D. Sullivan, Scott D. Ramsey, and Todd A. Lee. The Economic Burden of COPD, Chest, 2000; 117; 5-9.
7. K. J. R. Murthy, J. G. Sastry, Economic burden of chronic obstructive lung disease, National commission on macroeconomics and health-Burden of disease in India. 2005; 264-271.
8. Manik Chandra Shill, Asish Kumar Das. Medication practices in Bangladesh-Roles of pharmacists at current circumstances. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; Vol. 3 (4); 5-8.
9. Thomas Reema, Ramesh Adepu, Thomas Sabin. Impact of clinical pharmacist intervention on knowledge, attitude and practice (KAP) of patients with chronic obstructive pulmonary disease. International Journal of Pharmacy and Pharmaceutical Sciences. 2010; Vol. 2 (4); 54-57.
10. D. Mishra and H. P. Singh, Kuppuswamy's socioeconomic status scale-A revision, Ind J of Pediatrics, 2003, Vol. 70, 273-74.
11. Charles M. Fogarty et al. Comparison of a 5 day regimen of cefdinir with a 10 day regimen of cefprozil for treatment of acute exacerbation of chronic bronchitis, Journal of antimicrobial chemotherapy, 2000: 45, 851-852.
12. GK Kong, MJ Belman and S Weingarten. Reducing Length of Stay for Patients Hospitalized With Exacerbation of COPD by Using a Practice Guideline, Chest, 1997; 111; 89-94.
13. Olli Säynäjäkangas, Tuija Kinnunen, Tuili Tuuponen, Timo Keistinen. Length of stay and interval to readmission in emergency hospital treatment of COPD, Age and Ageing Advance Access published, 2004: doi: 10. 1093/ageing/afh188, 1-4.
14. Marc Miravitlles et al. Costs of chronic bronchitis and COPD: A year follow-up study, Chest, 2003; 123; 784-791.
15. Albert I Wertheimer, Nicole Chaney. Pharmacoeconomics, Business briefing: pharmagenerics, 2003.
16. Rachael Fleurene, Msc. Pharmacoeconomics, An introduction to pharmacoeconomics, The pharmaceutical journal, 2003: 271, 679-681
17. Prescott E, Lange P, Vestbo J. Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. Eur Respir J, 1999; 13(5): 1109-14.
18. Charles L. Emerman, David Effron, and Thomas W Lukens. Spirometric Criteria for Hospital Admission of Patients with Acute Exacerbation of COPD, Chest, 1991; 99: 595-599.
19. Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive pulmonary disease: (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med, 1996; 154: 959-967.